kennzo

CDNA (CareDx, Inc.) - Bullish end to the Quarter

Long
kennzo Pro Updated   
NASDAQ:CDNA   CareDx, Inc
CDNA

CareDx , Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx , Inc. is based in Brisbane, California.

Analysis/Commentary
Strong EPS and Sales Growth Y-on-Y

Based on the study of the previous quarterly earnings reports and subsequent price moves:
- Shaky start to the first half of the quarter
- Room for a return to at least the LOW point
- Trailing stop-loss on price above LOW point

GOOD LUCK.
DO YOUR OWN RESEARCH!
Comment: TRADE UPDATE: Successful
Exit trade for profits prior to earnings call
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.